Payment overview · 2025
General Payments
$995.34
40 reported records · 7 companies
Healthcare provider profile · identity verified
Alan E. Leifeste, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · KINGSLAND, TX · NPI 1700988714
Verified facts
What the public records show
CMS Open Payments records show Alan E. Leifeste, M.D. received $995.34 in general payments during 2025 across 40 reported records.
Amgen Inc. accounted for 31.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Symbicort by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 165 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $317.33 | 31.9% | 25 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $174.82 | 17.6% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $145.67 | 14.6% | 1 | 2025 |
| Teleflex LLC | Unresolved — no canonical attribution shown | $110.93 | 11.1% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $107.69 | 10.8% | 6 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $104.31 | 10.5% | 4 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $34.59 | 3.5% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $995.34 | 40 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $253.48 | 21 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $253.48 | 21 | 2025 |
Source payment records
|
|||||
| CREO Normalized: creo |
Device | Globus Medical, Inc. | $174.82 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $145.67 | 1 | 2025 |
Source payment records
|
|||||
| BARRIGEL Normalized: barrigel |
Device | Teleflex LLC | $110.93 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $107.69 | 6 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $104.31 | 4 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $63.85 | 4 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $34.59 | 2 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $29.00 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 165 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
165 | 41 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1121 | 306 |
| Atorvastatin Calcium | Atorvastatin Calcium | 968 | 258 |
| Levothyroxine Sodium | Levothyroxine Sodium | 717 | 194 |
| Losartan Potassium | Losartan Potassium | 673 | 189 |
| Amlodipine Besylate | Amlodipine Besylate | 538 | 144 |
| Duloxetine Hcl | Duloxetine Hcl | 458 | 113 |
| Gabapentin | Gabapentin | 428 | 109 |
| Metformin Hcl Er | Metformin Hcl | 391 | 112 |
| Metoprolol Succinate | Metoprolol Succinate | 381 | 108 |
| Pantoprazole Sodium | Pantoprazole Sodium | 375 | 91 |
| Lisinopril | Lisinopril | 359 | 102 |
| Ezetimibe | Ezetimibe | 348 | 112 |
| Potassium Chloride | Potassium Chloride | 320 | 66 |
| Tamsulosin Hcl | Tamsulosin Hcl | 288 | 84 |
| Omeprazole | Omeprazole | 278 | 74 |
| Furosemide | Furosemide | 271 | 49 |
| Fluticasone Propionate | Fluticasone Propionate | 264 | 94 |
| Ozempic | Semaglutide | 255 | 57 |
| Metoprolol Tartrate | Metoprolol Tartrate | 235 | 55 |
| Citalopram Hbr | Citalopram Hydrobromide | 228 | 53 |
| Celecoxib | Celecoxib | 224 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 216 | 66 |
| Escitalopram Oxalate | Escitalopram Oxalate | 199 | 45 |
| Allopurinol | Allopurinol | 196 | 54 |
| Jardiance | Empagliflozin | 165 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 165 | 34 |
| Eliquis | Apixaban | 163 | 28 |
| Trazodone Hcl | Trazodone Hcl | 162 | 39 |
| Montelukast Sodium | Montelukast Sodium | 158 | 39 |
| Oxybutynin Chloride | Oxybutynin Chloride | 154 | 54 |
| Donepezil Hcl | Donepezil Hcl | 150 | 35 |
| Clonazepam | Clonazepam | 147 | 22 |
| Tramadol Hcl | Tramadol Hcl | 146 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 137 | 36 |
| Sertraline Hcl | Sertraline Hcl | 135 | 29 |
| Bupropion Xl | Bupropion Hcl | 132 | 38 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 127 | 33 |
| Meloxicam | Meloxicam | 123 | 36 |
| Carvedilol | Carvedilol | 110 | 26 |
| Finasteride | Finasteride | 110 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 108 | 39 |
| Famotidine | Famotidine | 107 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 101 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 101 | 21 |
| Synthroid | Levothyroxine Sodium | 100 | 26 |
| Simvastatin | Simvastatin | 96 | 26 |
| Repatha Sureclick | Evolocumab | 95 | 23 |
| Xarelto | Rivaroxaban | 94 | 11 |
| Testosterone Cypionate | Testosterone Cypionate | 93 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 91 | 27 |
| Alendronate Sodium | Alendronate Sodium | 86 | 25 |
| Myrbetriq | Mirabegron | 83 | 16 |
| Mirtazapine | Mirtazapine | 80 | 14 |
| Pregabalin | Pregabalin | 76 | 24 |
| Atenolol | Atenolol | 74 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 19 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 71 | 53 |
| Alprazolam | Alprazolam | 65 | 11 |
| Lamotrigine | Lamotrigine | 64 | 11 |
| Buspirone Hcl | Buspirone Hcl | 63 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 63 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 60 | 38 |
| Febuxostat | Febuxostat | 59 | suppressed |
| Metformin Hcl | Metformin Hcl | 58 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 55 | 14 |
| Valsartan | Valsartan | 55 | 16 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 54 | 14 |
| Prednisone | Prednisone | 54 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 53 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 53 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 52 | 15 |
| Methocarbamol | Methocarbamol | 52 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 52 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 51 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 49 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 48 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 47 | 19 |
| Midodrine Hcl | Midodrine Hcl | 47 | 11 |
| Spironolactone | Spironolactone | 47 | 11 |
| Valacyclovir | Valacyclovir Hcl | 47 | 18 |
| Levetiracetam | Levetiracetam | 45 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 39 | 13 |
| Januvia | Sitagliptin Phosphate | 38 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Torsemide | Torsemide | 35 | suppressed |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Baclofen | Baclofen | 34 | suppressed |
| Memantine Hcl | Memantine Hcl | 34 | suppressed |
| Nystatin | Nystatin | 34 | 19 |
| Trulicity | Dulaglutide | 34 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 33 | suppressed |
| Estradiol | Estradiol | 33 | 16 |
| Humalog Kwikpen U-100 | Insulin Lispro | 33 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Lorazepam | Lorazepam | 32 | 15 |
| Ondansetron Odt | Ondansetron | 32 | 15 |
| Temazepam | Temazepam | 32 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 32 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 30 | suppressed |
| Mupirocin | Mupirocin | 30 | 11 |
| Primidone | Primidone | 30 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 30 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 29 | suppressed |
| Irbesartan | Irbesartan | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 28 | suppressed |
| Sucralfate | Sucralfate | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Azithromycin | Azithromycin | 23 | 23 |
| Brilinta | Ticagrelor | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Klayesta | Nystatin | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 21 |
| Rasagiline Mesylate | Rasagiline Mesylate | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Zaleplon | Zaleplon | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Gemtesa | Vibegron | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 18 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Incontrol Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Etodolac | Etodolac | 16 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Nystop | Nystatin | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 12 |
| Potassium Citrate Er | Potassium Citrate | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Budesonide | Budesonide | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Np Thyroid | Thyroid,pork | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $995.34 · 40 records | Amgen Inc. | AIRSUPRA, BARRIGEL, CREO, EVENITY, INSPIRE, JARDIANCE, OTEZLA, PROLIA, REPATHA, The Cologuard Plus Collection Kit | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error